scholarly article | Q13442814 |
P2093 | author name string | Derynck R | |
Barcellos-Hoff MH | |||
Tsang ML | |||
Weatherbee JA | |||
P2860 | cites work | Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization | Q47181164 |
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment | Q67854780 | ||
Transforming growth factor-beta 1 expression in irradiated liver | Q68500485 | ||
Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3 | Q68532959 | ||
Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture | Q69936661 | ||
Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation | Q70664397 | ||
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium | Q24679838 | ||
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells | Q28305879 | ||
Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development | Q28587489 | ||
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes | Q33862469 | ||
Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland | Q34630674 | ||
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes | Q36220190 | ||
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin | Q36222838 | ||
Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1 | Q36531643 | ||
Multiple forms of TGF-beta: distinct promoters and differential expression | Q37343642 | ||
Induction of tissue-type plasminogen activator by ionizing radiation in human malignant melanoma cells | Q41140357 | ||
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity | Q41984680 | ||
Transforming growth factor-?1 localization in normal and psoriatic epidermal keratinocytes in situ | Q42465621 | ||
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix | Q43755354 | ||
Collagen metabolism in the murine colon following X irradiation | Q43889569 | ||
Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins | Q43997125 | ||
Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. | Q44273701 | ||
Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? | Q44529208 | ||
Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. | Q47180254 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 892-899 | |
P577 | publication date | 1994-02-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Transforming growth factor-beta activation in irradiated murine mammary gland | |
P478 | volume | 93 |
Q36734862 | Absence of Smad3 induces neutrophil migration after cutaneous irradiation: possible contribution to subsequent radioprotection |
Q28138090 | Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology |
Q35795094 | Active macrophage-associated TGF-beta co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries |
Q44201008 | Amifostine does not prevent activation of TGFbeta1 but induces smad 7 activation in megakaryocytes irradiated in vivo. |
Q37516225 | Application of nanotechnology to cancer radiotherapy |
Q34954894 | Applications of quantitative digital image analysis to breast cancer research |
Q39203685 | Barriers to Radiation-Induced In Situ Tumor Vaccination. |
Q91804918 | Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients |
Q33804111 | Bidirectional regulation of macrophage function by TGF-beta |
Q35180158 | Biological approaches to improve skeletal muscle healing after injury and disease |
Q34481866 | Blocking HIF-1α following radiotherapy to prolong and enhance the immune effects of radiotherapy: a hypothesis |
Q40719933 | Bystander effects in radiation-induced genomic instability |
Q51551651 | Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity. |
Q37008538 | Cancer as an emergent phenomenon in systems radiation biology |
Q34006311 | Cell signaling by reactive nitrogen and oxygen species in atherosclerosis |
Q77331854 | Changes in histology and fibrogenic cytokines in irradiated colorectum of two murine strains |
Q37106657 | Choreographing metastasis to the tune of LTBP. |
Q27021428 | Combining radiotherapy and cancer immunotherapy: a paradigm shift |
Q44348976 | Comparative gene expression analysis in mouse models for identifying critical pathways in mammary gland development |
Q46794933 | Consequences of epithelial or stromal TGFβ1 depletion in the mammary gland |
Q30356447 | Current clinical trials testing the combination of immunotherapy with radiotherapy. |
Q35774065 | Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells |
Q38219828 | Cytokine networks that mediate epithelial cell-macrophage crosstalk in the mammary gland: implications for development and cancer. |
Q89944648 | Determinants of Resistance to Checkpoint Inhibitors |
Q92670843 | Discovery of Novel Small Molecules that Block Myofibroblast Formation: Implications for Capsular Contracture Treatment |
Q46697459 | Dynamics of metalloproteinase-2 and -9, TGF-beta, and uPA activities during normoxic vs. hyperoxic alveolarization |
Q74812598 | Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage |
Q79817874 | Effect of combined spa-exercise therapy on circulating TGF-beta1 levels in patients with ankylosing spondylitis |
Q55478417 | Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells. |
Q52596335 | Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies. |
Q26853461 | Emerging Treatment Paradigms in Radiation Oncology |
Q34873610 | Endoglin haplo-insufficiency modifies the inflammatory response in irradiated mouse hearts without affecting structural and mircovascular changes |
Q43577795 | Estrogen and antiestrogen actions on transforming growth factorbeta (TGFbeta) in normal human breast epithelial (HBE) cells |
Q39307101 | Exosomes in Toxicology: Relevance to Chemical Exposure and Pathogenesis of Environmentally Linked Diseases. |
Q37896073 | Exploring anti-TGF-β therapies in cancer and fibrosis. |
Q42478625 | Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage |
Q36470965 | Fibrillin-containing microfibrils are key signal relay stations for cell function |
Q44770240 | Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution |
Q28386637 | Gamma-ray irradiation impairs dendritic cell migration to CCL19 by down-regulation of CCR7 and induction of cell apoptosis |
Q41702950 | Gene therapy for rheumatoid arthritis. Theoretical considerations. |
Q46790834 | Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli |
Q52625088 | Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes. |
Q38596007 | Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment |
Q39402222 | Heavy ions can enhance TGFβ mediated epithelial to mesenchymal transition |
Q36844002 | High glucose promotes collagen synthesis by cultured cells from rat cervical posterior longitudinal ligament via transforming growth factor-beta1. |
Q36877625 | High-throughput antibody-based assays to identify and quantify radiation-responsive protein biomarkers |
Q37676065 | Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy |
Q48193633 | Immune recognition of irradiated cancer cells |
Q104286922 | Immunity, Immunotherapy, and Rectal Cancer: A Clinical and Translational Science Review |
Q35795526 | Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. |
Q73746260 | Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate |
Q48193685 | Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. |
Q60959909 | Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend |
Q38543250 | In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment |
Q50527308 | Increased transforming growth factor beta (TGF-beta) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. |
Q54095773 | Induction of nitric oxide production in infiltrating leukocytes following in vivo irradiation of tumor-bearing mice. |
Q34616814 | Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. |
Q44064597 | Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis |
Q39233221 | Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts |
Q47109594 | Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis |
Q39626552 | Intercellular induction of apoptosis signalling pathways |
Q24685810 | Ionizing radiation induces heritable disruption of epithelial cell interactions |
Q36174551 | Ionizing radiation induces myofibroblast differentiation via lactate dehydrogenase |
Q37274962 | Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β. |
Q34371336 | Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors |
Q34334857 | It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment |
Q33962857 | Latency and activation in the control of TGF-beta |
Q35861493 | Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation |
Q35747946 | Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation |
Q24683923 | Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta |
Q28238140 | Latent transforming growth factor-beta: structural features and mechanisms of activation |
Q59133970 | Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response |
Q42451601 | Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues |
Q37371652 | Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling |
Q31861378 | Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury |
Q37690702 | Ltbp1L is focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution |
Q74812606 | Magnetic resonance imaging of induration in the irradiated breast |
Q38612468 | Matters of context guide future research in TGFβ superfamily signaling |
Q34791957 | MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. |
Q35788867 | Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation |
Q33927976 | Modulation of protein expression and activity by radiation: relevance to intracoronary radiation for the prevention of restenosis |
Q73789528 | Modulation of skin collagen metabolism by irradiation: collagen synthesis is increased in irradiated human skin |
Q55497904 | Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis. |
Q34142102 | Molecular mechanisms and treatment of radiation-induced lung fibrosis |
Q35165109 | NRF2 deficiency reduces life span of mice administered thoracic irradiation |
Q24797078 | New highlights on stroma-epithelial interactions in breast cancer |
Q37024029 | New rationales for using TGFbeta inhibitors in radiotherapy |
Q41130691 | New specific molecular targets for radio-chemotherapy of rectal cancer |
Q39025449 | Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells |
Q36559256 | Novel Smad proteins localize to IR-induced double-strand breaks: interplay between TGFβ and ATM pathways |
Q37071457 | Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation |
Q92573136 | Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma |
Q34025940 | Pathogenesis of liver fibrosis: role of oxidative stress |
Q37503365 | Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor. |
Q34851427 | Pelvic radiation and anorectal function: introducing the concept of sphincter-preserving radiation therapy |
Q35610513 | Pharmacogenomics and breast cancer |
Q28344659 | Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation |
Q73677998 | Plasma TGFbeta level in rats after hemithoracic irradiation |
Q33921008 | Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium |
Q37214246 | Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases |
Q37693531 | Proteasomal regulation of pulmonary fibrosis |
Q36109855 | Protons sensitize epithelial cells to mesenchymal transition |
Q24620175 | Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type |
Q34472892 | Radiation and the microenvironment - tumorigenesis and therapy |
Q36347177 | Radiation as an immunological adjuvant: current evidence on dose and fractionation. |
Q37387399 | Radiation carcinogenesis in context: how do irradiated tissues become tumors? |
Q34131280 | Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited |
Q45058787 | Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. |
Q38698175 | Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection |
Q38244955 | Radiation-induced morphea - a literature review. |
Q28756266 | Radiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosis |
Q27022685 | Radiotherapy and the tumor stroma: the importance of dose and fractionation |
Q60954603 | Radiotherapy as a New Player in Immuno-Oncology |
Q33605773 | Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting |
Q46272741 | Reactive oxygen species as signaling molecules in the development of lung fibrosis |
Q24320337 | Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo |
Q38851167 | Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins |
Q35534311 | Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis |
Q51161086 | Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrence. |
Q38676730 | Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis |
Q44349351 | Role of nitric oxide in radiation-induced initiation of mammary tumorigenesis in rats |
Q35170428 | Role of tissue stroma in cancer cell invasion |
Q33920067 | Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing |
Q38261023 | Significant fibrosis after radiation therapy in a patient with Marfan syndrome |
Q35901168 | Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines |
Q35779047 | Smad3 as a mediator of the fibrotic response |
Q34745097 | Stromal mediation of radiation carcinogenesis |
Q33804136 | TGF-beta and cancer. |
Q33913350 | TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? |
Q74649751 | TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis |
Q28141342 | TGF-beta: from latent to active |
Q33566661 | TGF-β activation and function in immunity |
Q37899212 | TGF-β signaling in fibrosis |
Q46113966 | TGF-β1 Signaling and Tissue Fibrosis |
Q35908369 | TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity |
Q28083107 | TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis |
Q39155151 | Targeting TGF-β Signaling for Therapeutic Gain |
Q73516006 | The 90-day coronary vascular response to (90)Y-beta particle-emitting stents in the canine model |
Q59355701 | The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers |
Q54942438 | The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules. |
Q89286757 | The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome |
Q64986292 | The Role of Nrf2 in the Response to Normal Tissue Radiation Injury. |
Q27303974 | The TGF-β/Smad repressor TG-interacting factor 1 (TGIF1) plays a role in radiation-induced intestinal injury independently of a Smad signaling pathway |
Q28744461 | The difficulty of targeting cancer stem cell niches |
Q53591065 | The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. |
Q86940390 | The evolution of the cancer niche during multistage carcinogenesis |
Q37096652 | The immune system and cardiac repair. |
Q28137622 | The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis |
Q35056031 | The not-so innocent bystander: the microenvironment as a therapeutic target in cancer |
Q27024106 | The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation |
Q37161329 | The pathogenesis of cardiac fibrosis. |
Q33923770 | The potential influence of radiation-induced microenvironments in neoplastic progression |
Q43219957 | The predictive value of genes of the TGF-beta1 pathway in multimodally treated squamous cell carcinoma of the esophagus. |
Q37560277 | The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. |
Q40861074 | The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. |
Q33180660 | The role of TGF-beta in patterning and growth of the mammary ductal tree |
Q38536374 | The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence |
Q33962884 | Therapeutic implications of the TGF-beta system |
Q36610882 | Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients |
Q37808014 | Transforming growth factor (TGF)-β signaling in cardiac remodeling. |
Q36135981 | Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients |
Q44251117 | Transforming growth factor beta expression during an inner ear immune response |
Q41391410 | Transforming growth factor beta s and wound healing |
Q36518598 | Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis |
Q24793194 | Transforming growth factor-beta and breast cancer: Mammary gland development |
Q41096355 | Transforming growth factor-beta in breast cancer: a working hypothesis |
Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
Q41196594 | Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. |
Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
Q37633861 | Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas |
Q37192207 | Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation |
Q73247690 | [Radiation-induced superficial fibrosis and TGF-alpha 1] |
Search more.